Trial intelligence / Profile preview

Transdermal testosterone for SSRI-associated sexual dysfunction in midlife women with depression

ACTRN12610001079033Phase 2Completed

Sponsor
Monash University
Start
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in sexual dysfunction and major depressive disorder (MDD) comparing Transdermal testosterone with Placebo patch (2 arms). Primary endpoint: Change from baseline in total Sabbatsberg Sexual Self-rating Scale score. Started Mar 2011; status: completed.

02

Drugs

testosterone
03

Conditions

sexual dysfunctionmajor depressive disorder (MDD)

Beyond the preview

Go deeper on ACTRN12610001079033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610001079033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call